Anti-Junctional Adhesion Molecule 1 (Junctional Adhesion Molecule A, JAM-A, JAM-1, Platelet Adhesion

The members of junctional adhesion molecules family are type I transmembrane receptors belonging to the immunoglobulin (Ig) superfamily. Human JAM-A, also known as platelet adhesion molecule 1 (PAM-1) and platelet F11 receptor, is predominantly expressed at intercellular junctions of both epithelial cells and endothelial cells. It is also expressed on circulating blood cells including neutrophils, monocytes, platelets, erythrocytes, and lymphocytes. JAM-A exhibits homophilic interactions to regulate tight junction assembly and modulate paracellular permeability. This homophilic interaction also mediates platelet aggregation and adhesion to endothelial cells and may play a role in thrombosis. The human and mouse proteins share ~67% aa sequence homology. Human JAM-A also shares ~35% and 32% aa sequence homology with human JAM-B and JAM-C. Applications: Suitable for use in Flow Cytometry. Other applications not tested. Recommended Dilution: Optimal dilutions to be determined by the researcher. Excitation: 620-650nm , Emission: 660-670nm, Storage and Stability: May be stored at 4°C before opening. DO NOT FREEZE! Stable at 4°C as an undiluted liquid. Dilute only prior to immediate use. Stable for 12 months. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer. APC is light sensitive.